Page 13 - David Ricks News Today

Eli Lilly rode soaring demand for diabetes and weight-loss treatments to a better-than-expected finish in 2023, and the drugmaker expects momentum to carry into the new year.

Eli Lilly blew past Wall Street estimates for its latest earnings but faces pressure ahead to deliver strong results for the year.

Benchmark gauges notched all-time highs as stocks charged through a busy earnings season.

A new study in mice shows that replacement of a dysfunctional gene could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disorder in which the muscular walls of the heart progressively weaken and put patients at risk of dangerous irregular heartbeats.

Palm Beach County officials say the delay-plagued Lyons Road widening project will be completed by the end of July.

The World Health Organization (WHO) on Monday warned that global shortages last year of popular diabetes medicines that are also used for weight loss, such as Novo Nordisk's...

/PRNewswire/ -- A new study in mice shows that replacement of a dysfunctional gene could prolong survival in some people with arrhythmogenic right ventricular...

The World Health Organization on Monday warned that global shortages last year of popular diabetes medicines that are also used for weight loss, such as Novo Nordisks Ozempic, had been linked to...

The World Health Organization (WHO) on Monday warned that global shortages last year of popular diabetes medicines that are also used for weight loss, such as Novo Nordisk's Ozempic, had been linked to rising reports of suspected counterfeits. The organization said fake versions of the drugs, which belong to a class called GLP-1 agonists, are most often sold and distributed through unregulated outlets, including social media platforms, and carry serious health risks. Explosive demand for ...

U.S. stocks are up ahead of the January's meeting, as investors take in a slew of earnings results.